https://pmcpa.org.uk

The Prescription Medicines Code of Practice Authority | PMCPAPMCPAPMCPA | Prescription Medicines Code of Practice AuthorityThe Prescription Medicines Code of Practice Authority | PMCPA Skip to main content Code 2024 ABPI Code of Practice launched, with a new constitution and procedure for the PMCPA 2024 Interactive ABPI Code of Practice Documents outlining the changes to the ABPI Code Previous Codes of Practice Guidance and Q&As Guidance Q&As by Topic OR Clause 2024 Code Clause 12 Q&As 2024 Code Clause 10.4 Q&As PMCPA social media guidance Cases Ongoing cases Completed cases Advertised Sanctions Complaints procedure Before you send us your complaint, have you come to the right place? Make a complaint Responding to a complaint Abridged complaints procedure Pilot Limitation Period Policy Intercompany complaints Intercompany dialogue Compliance with intercompany undertakings Appeal procedures Administrative charges Sanctions Privacy Policy for Complaints Search the site About us Media Publications Training Contact us eAlert Code 2024 ABPI Code of Practice launched, with a new constitution and procedure for the PMCPA 2024 Interactive ABPI Code of Practice Documents outlining the changes to the ABPI Code Previous Codes of Practice Guidance and Q&As Guidance Q&As by Topic OR Clause 2024 Code Clause 12 Q&As 2024 Code Clause 10.4 Q&As PMCPA social media guidance Cases Ongoing cases Completed cases Advertised Sanctions Complaints procedure Before you send us your complaint, have you come to the right place? Make a complaint Responding to a complaint Abridged complaints procedure Pilot Limitation Period Policy Intercompany complaints Intercompany dialogue Compliance with intercompany undertakings Appeal procedures Administrative charges Sanctions Privacy Policy for Complaints The Prescription Medicines Code of Practice Authority The Prescription Medicines Code of Practice Authority (PMCPA) is the self-regulatory body which administers the Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry, independently of the ABPI. It was established by the ABPI on 1 January 1993. The Authority is responsible for the provision of advice, guidance and training on the Code as well as for the complaints procedure. It is also responsible for arranging for conciliation between companies when requested to do so and for arranging for the scrutiny of advertising and meetings on a regular basis. About us Latest PMCPA News - click tiles below ABPI Code training – four dates available to book Click here Hot topics on-demand webinars Click here PMCPA PRESS RELEASE 13 March 2026 - Case ruled in breach of Clause 2 Click here News Training New PMCPA learning portal 2026 PMCPA learning portal An interactive e-learning module targeted at individuals requiring an overview of the ABPI Code. On-demand webinars are also available  Click here for further details   Examinations The representative examinations In relation to extensions to the time period to take and pass the ABPI Advanced Programme for Industry Personnel (previously called ABPI Medical Representatives Examination) and the ABPI Intermediate Programme for Industry Personnel (previously called ABPI Generic Sales Representatives Examination) please click here ABPI Code Of Practice training ABPI Code training available in 2026 ABPI Code training delivered by members of the PMCPA Code of Practice Panel is now available to book. There are four dates available - click for further details.   The Appeal Board can impose additional sanctions in cases where:  the Appeal Board rules a breach of the Code, or  a breach of the Code has been accepted by the Company at the Panel level, or the Panel reports a Company to the Appeal Board. Corrective Statements, Public Reprimands and Advertisements (from May 2011 onwards) can be accessed below. Details of Audits, Re-Audits and the Recovery of items are included in the individual case reports. The PMCPA advertises brief details of all cases where companies are ruled in breach of Clause 2 of the Code, are required to issue a corrective statement or are the subject of a public reprimand in the medical and pharmaceutical press: the British Medical Journal and the Nursing Standard.  Advertised Sanctions Cases Complaints considered by the Code of Practice Panel are judged on the evidence provided by both parties. Once concluded a case report is published on this website. Good compliance decisions rely on both the interpretation of the Code and an understanding of its application, published case reports help in this regard and set precedent in a particular set of circumstances. When making decisions on compliance with the Code, knowledge gained from previous case reports can be beneficial. Completed cases are published here Completed cases Publications ABPI Code of Practice 2024 Optional HCP HCO Methodological Note Template Annual report 2024 ABPI Code of Practice 2021 Publications Back to top The PMCPA is a division of the ABPI which is a company limited by guarantee registered in England & Wales no 09826787. Registered office 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB. Useful links Privacy Accessibility Terms & Conditions Our locations Prescription Medicines Code of Practice Authority 2nd Floor Goldings HouseHay’s Galleria2 Hay’s LaneLondonSE1 2HB Directions Switchboard - 020 7747 8880 Emailenen1774376041https://pmcpa.org.uk

Saytınızı redaktə etmək istəyirsiniz?

Nə edirsən?